Figure 3 | Scientific Reports

Figure 3

From: Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China

Figure 3

Integrative OCVDAE ontology representation of drugs, AEs, drug ingredients, and MoAs. This is a screenshot of Protégé OWL editor of a subset of OCVDAE after OntoFox extraction of two Fluvastatin drugs and their associated terms from OCVDAE. As shown in this figure, OCVDAE imports many terms from NDF-RT and OAE and uses the BFO as the upper level ontology. Each drug (e.g., Fluvastatin NA 20 MG CAP) is associated with its ingredient, MoA, and specific AE terms (e.g., paresis AE). These terms and their parent upper level terms are organized in a well-defined hierarchy in OCVDAE.

Back to article page